HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A possible circulating plasma factor in Duchenne muscular dystrophy.

Abstract
Basal (Na+, K+)AtPase activity was found to be significantly reduced in erythrocyte ghosts from patients with Duchenne muscular dystrophy, and, whereas ouabain inhibited enzyme activity in controls, it stimulated activity in patients. Prior incubation of normal erythrocyte ghosts in Duchenne plasma resulted in an increase in enzyme activity on subsequent exposure to ouabain. This suggests there may be a "circulating plasma factor" in Duchenne muscular dystrophy responsible for the abnormal response to ouabain. This "factor" was rendered inactive by dialysis or deproteination of the plasma.
AuthorsS J Lloyd, A E Emery
JournalClinica chimica acta; international journal of clinical chemistry (Clin Chim Acta) Vol. 112 Issue 1 Pg. 85-90 (Apr 27 1981) ISSN: 0009-8981 [Print] Netherlands
PMID6263519 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Blood Proteins
  • DMD circulating plasma factor
  • Ouabain
  • Sodium-Potassium-Exchanging ATPase
Topics
  • Blood Proteins
  • Erythrocyte Membrane (enzymology)
  • Humans
  • Muscular Dystrophies (blood)
  • Ouabain (pharmacology)
  • Reference Values
  • Sodium-Potassium-Exchanging ATPase (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: